Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
burger-menu close-panel
🤝 We're Hiring! Apply now to join the Lozier Institute team
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

mifepristone

mifepristone

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
14 results

Filter Results By

Filter Applied. Clear All

Latest Posts

October 4, 2024 Scientists Sue Publisher Over Retractions Of Studies Showing Dangers Of Abortion Pills Scientists Sue Publisher Over Retractions Of Studies Showing Dangers Of Abortion Pills October 4, 2024 Scientists Sue Over ‘Discriminatory’ Retraction Of Studies Exposing Abortion Pill Dangers Scientists Sue Over ‘Discriminatory’ Retraction Of Studies Exposing Abortion Pill Dangers October 3, 2024 ADF, Consovoy McCarthy sue academic publisher for politically motivated retractions ADF, Consovoy McCarthy sue academic publisher for politically motivated retractions
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

14 results
mifepristone

Primer: The Basic Biochemistry of Abortion Pill Reversal

This primer lays out the science behind Abortion Pill Reversal by examining the function of progesterone as a naturally occurring hormone in the female reproductive system, the functions of mifepristone and misoprostol as drugs used in drug-induced abortion, the basic biochemical principle of competitive inhibition, and the disinformation surrounding the role of progesterone in reversing the abortion drug.

charlotte-lozier-institute Charlotte Lozier Institute
June 27, 2024
Please login to bookmarkClose
featured-image
mifepristone

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Ingrid Skop, M.D., FACOG
May 23, 2024
Please login to bookmarkClose
featured-image
mifepristone

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to remove medical safeguards and in-person administering of abortion drugs. These flaws illustrate the ongoing problem of lack of quality abortion reporting data in the U.S. as well as in the United Kingdom.

charlotte-lozier-institute Charlotte Lozier Institute
May 13, 2024
Please login to bookmarkClose
mifepristone

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepristone is not "safe," that the FDA's loosening of mifepristone regulations makes these safety concerns even worse, and that AHM et al. have standing, since they would suffer concrete injury under the current loosened mifepristone regulations, being at risk of finding themselves complicit in abortion procedures.

charlotte-lozier-institute Charlotte Lozier Institute
March 21, 2024
Please login to bookmarkClose
featured-image
mifepristone

Scientists to SCOTUS: FDA Harms Women & Doctors by Allowing Dangerous Mail-Order Abortion Drugs

As the nation’s leading pro-life scientific, statistical and research center, the Charlotte Lozier Institute has filed an amicus brief asking the Supreme Court to affirm the 5th U.S. Circuit Court of Appeals decision that found the FDA likely violated the law when it loosened safeguards on abortion drugs by allowing them to be sent by mail.

charlotte-lozier-institute Charlotte Lozier Institute
March 21, 2024
Please login to bookmarkClose
mifepristone

Induced Abortion with Misoprostol Alone

As abortion limits have been implemented in many states in the wake of the Supreme Court’s Dobbs decision, some perplexing recommendations have been advanced by abortion advocates and their media allies.

Ingrid Skop, M.D., FACOG
May 18, 2023
Please login to bookmarkClose
mifepristone

Lozier Institute Statement on Abortion Pill Lawsuit Filed by Alliance Defending Freedom

Charlotte Lozier Institute, which in 2021 revealed a dramatic surge in abortion pill-related emergency room visits, today applauded Alliance Defending Freedom for challenging the U.S. Food and Drug Administration’s (FDA) erroneous and highly-politicized approval of the abortion drug regimen.

charlotte-lozier-institute Charlotte Lozier Institute
November 18, 2022
Please login to bookmarkClose
mifepristone

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell a doctor about an abortion.”

charlotte-lozier-institute Charlotte Lozier Institute
May 25, 2022
Please login to bookmarkClose

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image